Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
November 14, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray Medical announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH (“Aphria RX”) facility.
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
November 07, 2024 07:00 ET
|
Tilray Brands, Inc.
This trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from negative chemotherapy-induced side effects.
International Directory of Medical Cannabis Companies 2024
October 04, 2024 04:54 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "International Directory of Medical Cannabis Companies 2024" directory has been added to ResearchAndMarkets.com's offering.The International Directory...
Tilray Medical Launches Redecan Cannabis Brand in Australia
September 18, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray's EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical Prescription.
Organic Remedies Raises $15,000 for Speranza Animal Rescue
September 17, 2024 08:15 ET
|
Organic Remedies
Organic Remedies proudly announced it has raised $15,000 for Speranza Animal Rescue during its month-long Dog Days of Summer campaign in August.
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
September 09, 2024 07:00 ET
|
Tilray Brands, Inc.
LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the...
World Cannabis Market Report 2024: Examining Five Drivers Shaping Legal Cannabis
September 06, 2024 05:22 ET
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "World Market for Cannabis" report has been added to ResearchAndMarkets.com's offering. Backed partly by existing legacy use, there is a broad-based...
Europe Medical Cannabis Market Forecast 2024-2032: Tilray, Aurora Cannabis, and GW Pharmaceuticals Dominate the Market Landscape
August 29, 2024 05:12 ET
|
Research and Markets
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "Europe Medical Cannabis Oil Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2024-2032." report has been added to ...
Australia Medical Cannabis Market Size, Share & Trends Analysis Report 2024-2030: Entry Of International Players, Consumer Shift in Education, Increasing Preference for Oils and Tinctures
August 13, 2024 10:27 ET
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Australia Medical Cannabis Market Size, Share & Trends Analysis Report by Application (Cancer, AIDS), Sources (Hemp, Marijuana), Derivatives (CBD,...
Germany Legal Cannabis Market Analysis 2024-2030 by Source (Hemp, Marijuana), Derivatives (CBD, THC)
August 12, 2024 09:28 ET
|
Research and Markets
Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Germany Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Hemp, Marijuana), Derivatives (CBD, THC), End-use, and Segment...